These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
169 related articles for article (PubMed ID: 30292628)
1. Development of a Prediction Tool for Exclusive Locoregional Recurrence After Radical Cystectomy in Patients With Muscle-Invasive Bladder Cancer. Necchi A; Pond GR; Moschini M; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Vaishampayan U; Theodore C; Sridhar SS; Rosenberg JE; Bellmunt J; Gallina A; Colombo R; Montorsi F; Briganti A; Galsky MD Clin Genitourin Cancer; 2019 Feb; 17(1):7-14.e3. PubMed ID: 30292628 [TBL] [Abstract][Full Text] [Related]
2. Modeling 1-year Relapse-free Survival After Neoadjuvant Chemotherapy and Radical Cystectomy in Patients with Clinical T2-4N0M0 Urothelial Bladder Carcinoma: Endpoints for Phase 2 Trials. Bandini M; Briganti A; Plimack ER; Niegisch G; Yu EY; Bamias A; Agarwal N; Sridhar SS; Sternberg CN; Vaishampayan U; Théodore C; Rosenberg JE; Bellmunt J; Galsky MD; Montorsi F; Necchi A Eur Urol Oncol; 2019 May; 2(3):248-256. PubMed ID: 31200838 [TBL] [Abstract][Full Text] [Related]
3. Locoregional recurrence after cystectomy in muscle invasive bladder cancer: Implications for adjuvant radiotherapy. Murthy V; Bakshi G; Manjali JJ; Prakash G; Pal M; Joshi A; Dholakia K; Bhattacharjee A; Talole S; Puppalwar A; Srinivasan S; Panigrahi G; Salunkhe R; Menon S; Noronha V; Prabhash K; Krishnatry R Urol Oncol; 2021 Aug; 39(8):496.e9-496.e15. PubMed ID: 33573998 [TBL] [Abstract][Full Text] [Related]
4. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [TBL] [Abstract][Full Text] [Related]
5. External validation of preoperative and postoperative nomograms for prediction of cancer-specific survival, overall survival and recurrence after robot-assisted radical cystectomy for urothelial carcinoma of the bladder. Al-Daghmin A; English S; Kauffman EC; Din R; Khan A; Syed JR; Sztorc J; Mehedint D; Sharif M; Shi Y; Wilding G; Guru KA BJU Int; 2014 Aug; 114(2):253-60. PubMed ID: 24119175 [TBL] [Abstract][Full Text] [Related]
6. Prediction of cancer-specific survival after radical cystectomy in pT4a urothelial carcinoma of the bladder: development of a tool for clinical decision-making. Aziz A; Shariat SF; Roghmann F; Brookman-May S; Stief CG; Rink M; Chun FK; Fisch M; Novotny V; Froehner M; Wirth MP; Schnabel MJ; Fritsche HM; Burger M; Pycha A; Brisuda A; Babjuk M; Vallo S; Haferkamp A; Roigas J; Noldus J; Stredele R; Volkmer B; Bastian PJ; Xylinas E; May M BJU Int; 2016 Feb; 117(2):272-9. PubMed ID: 25381844 [TBL] [Abstract][Full Text] [Related]
7. External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder. Nuhn P; May M; Sun M; Fritsche HM; Brookman-May S; Buchner A; Bolenz C; Moritz R; Herrmann E; Burger M; Tilki D; Trojan L; Perrotte P; Haferkamp A; Hohenfellner M; Wieland WF; Müller SC; Karakiewicz PI; Bastian PJ Eur Urol; 2012 Jan; 61(1):58-64. PubMed ID: 21840642 [TBL] [Abstract][Full Text] [Related]
8. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer. Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847 [TBL] [Abstract][Full Text] [Related]
13. Development and validation of a prognostic nomogram for predicting cancer-specific survival after radical cystectomy in patients with bladder cancer:A population-based study. Yang Z; Bai Y; Liu M; Hu X; Han P Cancer Med; 2020 Dec; 9(24):9303-9314. PubMed ID: 33063464 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of Adjuvant Chemotherapy After Radical Cystectomy for Locally Advanced and/or Pelvic Lymph Node-Positive Muscle-invasive Urothelial Carcinoma of the Bladder: A Propensity Score-Weighted Competing Risks Analysis. Vetterlein MW; Seisen T; May M; Nuhn P; Gierth M; Mayr R; Fritsche HM; Burger M; Novotny V; Froehner M; Wirth MP; Protzel C; Hakenberg OW; Roghmann F; Palisaar RJ; Noldus J; Pycha A; Bastian PJ; Trinh QD; Xylinas E; Shariat SF; Rink M; Chun FK; Dahlem R; Fisch M; Aziz A; Eur Urol Focus; 2018 Mar; 4(2):252-259. PubMed ID: 28753775 [TBL] [Abstract][Full Text] [Related]
16. Extranodal extension is a powerful prognostic factor in bladder cancer patients with lymph node metastasis. Fajkovic H; Cha EK; Jeldres C; Robinson BD; Rink M; Xylinas E; Chromecki TF; Breinl E; Svatek RS; Donner G; Tagawa ST; Tilki D; Bastian PJ; Karakiewicz PI; Volkmer BG; Novara G; Joual A; Faison T; Sonpavde G; Daneshmand S; Lotan Y; Scherr DS; Shariat SF Eur Urol; 2013 Nov; 64(5):837-45. PubMed ID: 22877503 [TBL] [Abstract][Full Text] [Related]
17. Prediction of 90-day mortality after radical cystectomy for bladder cancer in a prospective European multicenter cohort. Aziz A; May M; Burger M; Palisaar RJ; Trinh QD; Fritsche HM; Rink M; Chun F; Martini T; Bolenz C; Mayr R; Pycha A; Nuhn P; Stief C; Novotny V; Wirth M; Seitz C; Noldus J; Gilfrich C; Shariat SF; Brookman-May S; Bastian PJ; Denzinger S; Gierth M; Roghmann F; Eur Urol; 2014 Jul; 66(1):156-63. PubMed ID: 24388438 [TBL] [Abstract][Full Text] [Related]
18. Nomogram Predicting Bladder Cancer-specific Mortality After Neoadjuvant Chemotherapy and Radical Cystectomy for Muscle-invasive Bladder Cancer: Results of an International Consortium. Mir MC; Marchioni M; Zargar H; Zargar-Shoshtari K; Fairey AS; Mertens LS; Dinney CP; Krabbe LM; Cookson MS; Jacobsen NE; Griffin J; Montgomery JS; Vasdev N; Yu EY; Xylinas E; McGrath JS; Kassouf W; Dall'Era MA; Sridhar SS; Aning J; Shariat SF; Wright JL; Thorpe AC; Morgan TM; Holzbeierlein JM; Bivalacqua TJ; North S; Barocas DA; Lotan Y; Grivas P; Stephenson AJ; Shah JB; van Rhijn BW; Spiess PE; Daneshmand D; Black PC Eur Urol Focus; 2021 Nov; 7(6):1347-1354. PubMed ID: 32771446 [TBL] [Abstract][Full Text] [Related]
19. Impact of smoking and smoking cessation on outcomes in bladder cancer patients treated with radical cystectomy. Rink M; Zabor EC; Furberg H; Xylinas E; Ehdaie B; Novara G; Babjuk M; Pycha A; Lotan Y; Trinh QD; Chun FK; Lee RK; Karakiewicz PI; Fisch M; Robinson BD; Scherr DS; Shariat SF Eur Urol; 2013 Sep; 64(3):456-64. PubMed ID: 23206854 [TBL] [Abstract][Full Text] [Related]
20. Accurate preoperative prediction of non-organ-confined bladder urothelial carcinoma at cystectomy. Green DA; Rink M; Hansen J; Cha EK; Robinson B; Tian Z; Chun FK; Tagawa S; Karakiewicz PI; Fisch M; Scherr DS; Shariat SF BJU Int; 2013 Mar; 111(3):404-11. PubMed ID: 22805163 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]